Medicover AB (publ)(MCVEY)
USD --+0.00%
Reward65Moderate
Risk60Medium-High
📊75%Data
Thin 3% profit margin · Revenue growing 10% YoY
MCVEY
+0.0 · +0.00%
USD · PINK
Medicover AB (publ) | Healthcare
Growth Machine
Market Cap:2.50Bn
ℹ️
Reward Rating
65
Moderate
Top 50% (model universe)
75% data coverage
ℹ️
Risk Rating
60
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on MCVEY to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Medicover AB (publ)?

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally.

MCVEY · Verdict

Solid reward · elevated risk

MCVEY stands out on growth and cash flow, but watch the balance sheet signal.

Based on 88% data coverage

MCVEY · Verdict

What’s working & what to watch

Strengths 2

  • Growth89/100

    Rev +16.3% CAGR · earnings +87.3%

  • Cash flow71/100

    8% free-cash-flow margin

Watchouts 2

  • Balance sheet20/100

    Interest covered 2.5×

  • Volatility20/100

    Weak vs peers

Model-based scoring. For information only — not financial advice.

What is Medicover AB (publ)?

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. Its Healthcare Services include service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 2.50B, and a P/E ratio of 40.4x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Profitability metrics are mixed — margins may be under pressure.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (65)

The scoring profile indicates moderate reward potential, with growth and momentum as the leading contributors. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap2.50B
P/E Ratio40.3659
Dividend Yield1.21%
52 Week High21.54
52 Week Low16.3842
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding74M
No. of Employees49,000
IndustryMedical Care Facilities
ExchangePINK
Beta1.58
CurrencyUSD · Reports in EUR